Found 7 matching trials
Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) PHASE4 This is an investigator-initiated study of safety, efficacy and tolerabilit...
Show More Location
Deaconess Clinic Gateway Health Center
Learn More & Join Trial
Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome PHASE4 To investigate if oxybutynin ER adding on antimuscarinics is more effective...
Show More Location
Buddhist Tzu Chi General Hospital
Learn More & Join Trial
Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women PHASE4 The purpose of the study is to assess the impact of treatment with tolterod...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Assessment of Patient-reported Goal Attainment in the Treatment of Female Overactive Bladder PHASE4 For many years, antimuscarinics have been first-line pharmacological treatm...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) Patients PHASE4 This is a Phase IV, prospective, randomized, multi-center study to find ris...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Non-invasive Saphenous Nerve Stimulation Therapy for Overactive Bladder PHASE3 The goal of this clinical trial is to study the NiNA System and how it work...
Show More Location
Virtua Primary Care
Learn More & Join Trial
The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial PHASE3 The optimal medication for women with nocturia remains uncertain. This clin...
Show More Location
Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital,
Learn More & Join Trial